Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
   
 
                                                                                                
      
 
About Us
MISSION STATEMENT
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy (UHSP) in St. Louis continuing education provides learning opportunities to meet licensure requirements and professional development needs of pharmacy practitioners in a variety of practice settings throughout the region, including alumni, preceptors, and residents, through flexible continuing pharmacy education (CPE). CPE activities are delivered internally and collaboratively through regional joint providership agreements.
 
CONTINUING PHARMACY EDUCATION ADMINISTRATOR
Questions about CE? Please contact CE@uhsp.edu for assistance.
 

 
 
 
 
 
 
 
 
 

POLICY UPDATE & FAQ
 
On June 1, 2019, policies surrounding adjustments and corrections to CE credit as well as to registrations became effective. To learn more about these policies, or to read answers to other commonly asked questions, check out the FAQ page. Still don't see what you are looking for? Contact us.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              

 

 
 
Upcoming CE Activities

Resident Seminar: There will be three Resident Seminar sessions this fall. Each date of the series allows participants to choose from a variety of 45-minute live or virtual sessions, prepared by PGY1 and PGY2 pharmacy residents from the St. Louis metropolitan area. Pharmacists can earn a maximum of 2.25 of continuing pharmacy education credit per session, for a total of 6.75 CEUs for all three sessions.                                                                      

Session 3 - Thursday, December 15, 2022 - To learn more about this the Resident Seminar session, please click below.
 
Distance CE Activities for 2022

Expanded Role of Rivaroxaban in Patients with Diabetes and Coronary Artery Disease: Patients with diabetes mellitus (DM) are more likely to have cardiovascular (CV) disease and an increased thrombotic risk; therefore, aggressive management to prevent CV events is crucial. Join Dr. Ashley Lopez for a 45-minute presentation as she addresses emerging evidence on the potential use of dual pathway antithrombotic therapy with aspirin in combination with reduced-dose anticoagulant and stratify the clinical benefit in patients with diabetes mellitus and coronary artery disease.

To learn more about Expanded Role of Rivaroxaban in Patients with Diabetes and Coronary Artery Disease, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).

The Utilization of Medications that Augment the Nitric Oxide Pathway in Heart Failure Patients: Join Dr. Brooke Jacobson as she examine the role of medications that augment the nitric oxide pathway in patients with heart failure with reduced ejection fraction. This presentation will begin by describing the background, etiology, and prevalence of heart failure followed by the pathophysiology. The pathophysiology in this presentation will specifically cover how the nitric oxide pathway is altered in patients with heart failure. Current guideline recommendations for optimizing heart failure medications will be reviewed. The presentation will then look at literature available for the nitric oxide augmenting agents. The trials that study the effectiveness of hydralazine/isosorbide (V-HeFT trials and the A-HeFT trial) will be reviewed and analyzed as well as the VICTORIA trial. The VICTORIA trial evaluates the efficacy of the newest agent in this drug class- vericiguat. The presentation will conclude with an evaluation of how these agents should be used in current practice. A treatment algorithm will be included to guide the decision on who should receive these agents.

To learn more about Just Say NO to HFrEF: The Utilization of Medications that Augment the Nitric Oxide Pathway in Patients with Heart Failure, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).

A Closer Look at Episodic Migraine Prevention: Join Dr. Nicole Short for this 45-minute presentation where she discusses the characteristics of episodic migraine followed by an explanation of the mechanism of calcitonin gene-related peptide (CGRP) antagonists. An overview of current American Academy of Neurology recommendations and the European Headache Federation guidance on CGRP antagonists for episodic migraine prevention will be discussed. A literature review over the critical trials of injectable CGRP antagonists along with a trial of the first-line agent, topiramate will be presented. The findings of these trials will be compared and contrasted in order to help define the role and place in therapy for CGRP antagonists.

To learn more about A Closer Look at Episodic Migraine Prevention, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
 
Two's Company, Three's a Crowd: Optimizing Therapy for People Living with HIV: Join Dr. Leanne Allas for a 45-minute presentation where she will review the use of 2 drug antiretroviral regimens as treatment optimization for persons living with HIV. She will discuss available antiretroviral drug combinations to treat persons with HIV, benefits the switch from the traditional 3-drug antiretroviral regimens to 2-drug antiretroviral regimens, and current switch clinical studies. By the end of this presentation pharmacists will be able to identify patients that may be eligible for a switch to a 2-drug antiretroviral regimen.
 
To learn more about Two's Company, Three's a Crowd: Optimizing Therapy for People Living with HIV, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
 
Beta Blockade in Sepsis: Join Dr. Smith for a virtual presentation as he discusses the specific mechanisms in which sepsis and excessive sympathetic stimulation can result in cardiac dysfunction and the potential role ultrashort beta-blockers can have to overcome these negative effects. This session will focus on analyzing recent literature examining beta-blocker therapy in sepsis to identify patient characteristics that may see benefits or harms in receiving beta-blocker therapy.
 
To learn more about Beta Blockade in Sepsis, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
Link>>> 
 
Oral Antibiotics for Step-Down Therapy in Uncomplicated Gram-Negative Bacteremia: Join Dr. Jorns for this virtual home study presentation where she will review background information and current literature on step-down therapy to oral antibiotics in patients with gram-negative bacteremia. The presentation will begin by describing the epidemiology of and risk factors for gram-negative bacteremia. Next, common pathogens and principles of treatment will be reviewed, including several trials pertaining to seven versus fourteen days of antimicrobial therapy. Available literature pertaining to step-down in gram-negative bacteremia will be summarized followed by other pertinent retrospective case studies which include patients with bactermia due to a variety of sources. The presentation will then move into a review and analysis of a trial comparing fluoroquinolones to beta lactams as oral step-down agents as well as a large meta-analysis. The presentation will conclude with evaluation of how step-down to oral antibiotics fits into treatment algorithms for patients with gram-negative bacteremia. 
 
To learn more about Oral Antibiotics for Step-Down Therapy in Uncomplicated Gram-Negative Bacteremia, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
 
 
                                      Additional Distance CE Activities
 
Medical Cannabis for Pharmacists: Join Dr. Lauren Palmier for an enlightening virtual home study presentation where she discusses the basic pharmacokinetics and pharmacodynamics of cannabis, and the endocannabinoid system. Considering the recent legalization of marijuana usage for medicinal purposes, this activity educates pharmacists on drug interactions between medical cannabis and pharmaceutical prescription and non-prescription medications, as well as possible side effects and safety concerns.
 
To learn more about Medical Cannabis for Pharmacists, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
 
Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement: Join Dr. Allison Wicker as she assesses the available literature to develop an evidence-based recommendation on the optimal antithrombotic regimen following transcatheter aortic valve replacement. Pharmacists can earn .75 contact hours of knowledge-based CE credit at the completion of this activity. 
 
To learn more about Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement, please click below.
 
Darth Vapor: The JUUL of the Empire: Join Dr. Suzanne Bollmeier for a virtual home study event entitled Darth Vapor: The JUUL of the Empire. In this activity, Dr. Bollmeier discusses the different forms of electronic cigarettes and vaping devices used to deliver nicotine, and the educational messages pharmacists can use to educate adult and adolescent patients related to the dangers of vaping. Pharmacists can earn 1.0 contact hour of knowledge-based CE credit at the completion of this activity. 
 
To learn more about Darth Vapor: The JUUL of the Empire, please click the link below.
Link>>>
 
Emerging Targets for Multiple Myeloma: Join Dr. Adam Robinson for a virtual home study presentation discussing emerging new drug approvals and therapeutics surrounding chimeric antigen receptor CAR T-cell therapies in relapsed or refractory multiple myeloma. Pharmacists can earn .75 contact hours of knowledge-based CE credit at the completion of this activity. 
 
To learn more about Emerging Targets for Multiple Myeloma: B-cell Maturation Antigen (BCMA) Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy, please click below.
 
Introduction to Biosimilars: Join Dr. Michelle Sprout as she defines and reviews biological, biosimilars, and interchangeable products which are the fastest-growing class of therapeutic products in the U.S. and account for a substantial portion of health care costs. Pharmacists can earn .75 contact hour of knowledge-based CE credit at the completion of this activity. 
 
To learn more about Introduction to Biosimilars, please click the link below.
 
Utility of Nitric Oxide in Acute Pulmonary Embolism: Join Dr. Cody Craven as he reviews the existing literature surrounding the use of nitric oxide in patients with pulmonary embolism and the clinical challenges that   may arise with its usage. At the completion of this virtual home study activity entitled, Utility of Inhaled Nitric Oxide    in Acute Pulmonary Embolism, pharmacists can earn .75 contact hours of knowledge-based CE credit.
 
To learn more about Utility of Inhaled Nitric Oxide in Acute Pulmonary Embolism, please click the link below.
Link>>>
 
COVID-19 Treatment Options: COVID-19 is a worldwide pandemic causing unprecedented rates of infection and death. Please join Dr. Lindsey Eble in exploring the latest treatment options for COVID-19. This presentation will review the epidemiology of the current SARS-CoV2, viral structure and transmission. Participants will learn the six most studied/talked about treatments for COVID-19 and address the proposed mechanisms of action, limited in-vitro and clinical data, and risk benefits in the use of each therapeutic option.
 
To learn more about COVID-19: Treatment Options,  please click the link below.
Link>>>
 
 
         Hospice and Palliative Care: A Certificate Program for Pharmacists
20 Hour - Application CE Activity
 
We are pleased to announce Hospice and Palliative Care: A Certificate Program for Pharmacists. This online certificate program is designed to introduce pharmacists to end-of-life issues and the care of patients in hospice and palliative care while further exploring advanced symptom management. The 16 modules are presented by nationally-recognized experts in the field of hospice and palliative care. The participant will be introduced to many topics important in the development and maintenance of a hospice practice, working with and communicating within a hospice team, and managing common challenges in pain management. Participants will then build upon foundational knowledge and enhance their skills related to prevalent diseases and  disorders present at the end of life, such as gastrointestinal issues, psychiatric needs, and hematology. Finally, pharmacists will have an opportunity to apply their knowledge in practice and submit to receive a certificate.
 
To learn more about the Hospice and Palliative Care: A Certificate Program for Pharmacists, please click this link:
Link>>>
 
 
Programs Release Date Expiration Date Flyer Hours
Expanded Role of Rivaroxaban in Patients with Diabetes and Coronary Artery Disease 02/04/2022 02/04/2025 N.A. 0.75
Just Say NO to HFrEF: The Utilization of Medications that Augment the Nitric Oxide Pathway in Patients with Heart Failure 02/01/2022 02/01/2025 N.A. 0.75
A Closer Look at Episodic Migraine Prevention 01/24/2022 01/24/2025 N.A. 0.75
Two's Company, Three's a Crowd: Optimizing Therapy for People Living with HIV 01/21/2022 01/21/2025 N.A. 0.75
Beta Blockade in Sepsis 01/11/2022 01/11/2025 N.A. 0.75
Oral Antibiotics for Step-Down Therapy in Uncomplicated Gram-Negative Bacteremia 01/07/2022 01/07/2025 N.A. 0.75
Medical Cannabis for Pharmacists 09/28/2021 09/28/2024 N.A. 1.00
Introduction to Biosimilars 03/05/2021 02/10/2024 N.A. 0.75
Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement 02/22/2021 02/22/2024 N.A. 0.75
Emerging Targets for Multiple Myeloma: B-cell Maturation Antigen (BCMA) Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy 02/02/2021 02/02/2024 N.A. 0.75
Utility of Inhaled Nitric Oxide in Acute Pulmonary Embolism 02/12/2021 02/12/2024 N.A. 0.75
Darth Vapor: The JUUL of the Empire 11/12/2020 11/12/2023 N.A. 1.00
A Brief Update on the 2020 COPD Guidelines 08/18/2020 08/18/2023 N.A. 0.50
COVID-19: Treatment Options 04/20/2020 04/20/2023 N.A. 1.00
Heart Failure 04/23/2020 04/23/2023 N.A. 1.50
Hospice and Palliative Care: A Certificate Program for Pharmacists 07/21/2022 07/21/2025 N.A. 20.00